Abbott ABT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Diagnostic Products | $9.06B-1.3% | $8.94B-4.3% | $9B-3.8% | $9.16B-2.5% | $9.18B-3.5% | |
| Established Pharmaceuticals | $5.7B+9.1% | $5.54B+6.6% | $5.42B+5.3% | $5.32B+4.1% | $5.23B+2.4% | |
| Medical Devices | $22.03B+13.4% | $21.39B+12.6% | $20.76B+13.0% | $20.06B+12.2% | $19.43B+11.4% | |
| Nutritional Products | $8.32B-2.0% | $8.45B+0.5% | $8.64B+3.8% | $8.55B+2.7% | $8.49B+2.9% | |
| Net Sales by Geography | ||||||
| International | $27.9B+8.6% | $27.2B+6.1% | $26.76B+5.8% | $26.12B+3.7% | $25.7B+3.0% | |
| United States | $17.23B+3.5% | $17.13B+4.9% | $17.08B+7.2% | $16.99B+9.3% | $16.65B+8.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Abbott break its business down?
- Abbott (ABT) reports net sales by business across 4 parts — Diagnostic Products, Established Pharmaceuticals, Medical Devices and Nutritional Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Abbott's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Abbott's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
